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The TCR has been identified in several species as a heterodimer of two variable
chains (reviewed in reference 1) that is associated with a set of invariant polypep-
tides collectively referred to as CD3. MHC-restricted antigen recognition by both
cytotoxic (mostly CD8') and helper (mostly CD4') T cells is mediated by clono-
typic heterodimers of the a/ß type, while a second type of CD3-associated TCR,
termed y/S, has recently been discovered on a small subpopulation of human (2)
and mouse (3) T cells.
mAbs to the TCR and CD3 molecules have been instrumental to the discovery
and analysis of the TCR complex. Recent work in the mouse system has especially
profited from the generation of mAbs to Vß segments expressed at a frequency de-
tectable in unimmunized T cell populations (4-7), and to the invariant CD3E chain
(8) . No mAb to .a constant determinant of the mouse TCR-a/ß is available, how-
ever, that could be used to discriminate TCR-a/ß and TCR-,y/8 expressing T cells
and thymocytes. In the rat system, analysis of T cell maturation and activation has
been hampered by a complete lack of TCR- and CD3-specific monoclonal reagents,
despite an otherwise excellent collection of mAbs to cell surface molecules.
Here, we describe a new mAb, termed R73, that detects a rat pan T cell surface
antigen with the predicted properties of the TCR-a/ß on mature and immature cells
of the T cell lineage and reports its functional effects on resting T lymphocytes.
Materials and Methods
Animals.
￿
Young adult Wistar and Lewis rats ofboth sexes were obtained from the animal
quarters of the Max Planck Institute for Biochemistry, Martinsried, FRG, or from the Zen-
tralinstitut für Versuchstierzucht, Medizinische Hochschule Hannover, FRG. Results obtained
did not vary significantly between both strains.
Immunization and Cell Fusion.
￿
Spleen cells from a BALB/c mouse alternately immunized
intraperitoneally with rat T blasts and rat erythrocytes (it was also intended to generate an
mAb to rat LFA-3) were fused 3 d after an intravenous injection of 10' rat erythrocytes with
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the nonproducer cell line X63-Ag 8.653 using polyethylene glycol. Supernatants of hybrid-
omas obtained after selection in azaserine/hypoxanthine-containing medium were screened
for binding to rat T cell blasts by indirect immunofluorescence and flow cytometry. Positive
supernatants were screened at a 1 :4 final dilution for the induction of DNA synthesis in 105
unfractionated rat splenocytes (see below) . R73, the only positive culture among -4,000 hy-
bridomas, was subcloned by limiting dilution.
mAbs and Fluorochrome Conjugation.
￿
mAbs OX-35, W3/25 (both anti-CD4, reference 9),
OX-8 (anti-CD8, reference 10), OX-52 (pan T cell, reference 11), OX-39 (anti-IL-2-R, refer-
ence 12) OX-44 (13), and R73 were purified from ascitic fluid using protein A-sepharose
(Pharmacia Fine Chemicals, Uppsala, Sweden). mAb L180/1 to sheep LFA-3 (14) is of the
same isotype (y,) as R73 and was used as a negative control. All OX antibodies were the
kind gift of Dr. A. Williams, Oxford, England. They were conjugated with FITC (Sigma
Chemical Co., St. Louis, MO) according to standard procedures. Secondary antibodies were
FITC-labeled RaMIg Fabz and biotinylated RaMIg (both from Dakopatts GmbH, Ham-
burg, FRG). Avidin-phycoerythrin was obtained from Becton Dickinson GmbH, Heidelberg,
FRG.
Immune Histology.
￿
Detection of the R73 antigen in 5-um cryostat sections of lymphoid
organs was kindly performed by Dr. Louise Beyers, Oxford, following published procedures
(13).
Preparation of Cells.
￿
Cell suspensions from thymus, spleen, and pooled lymph nodes were
prepared by passing the organs through a metal grid into ice-cold balanced salt solution.
Bone marrow was ejected into balanced salt solution from femurs and tibias with a syringe.
Resting T cells were isolated from lymph node cell suspensions by passage over nylon wool
and by collecting the 50:60% Percoll (Pharmacia Fine Chemicals) interphase after density
centrifugation. Thymocyte subsets were isolated by two cycles of "panning" (15) on rabbit
anti-mouse Ig (RaMIg)'-coated plates to bind thymocytes that had been treated with mouse
mAb to various surface markers. Impurities in the subpopulations thus obtained were de-
tected by labeling with RaMIg-biotin and avidin-phycoerythrin, permitting their exclusion
by electronic gating when reactivity with FITC-conjugated R73 mAb was studied (see below).
Immunojluorescence and Flow Cytometry.
￿
All labeling reagents were used at saturing concen-
trations. For direct immunofluorescence, 2 x 105 cells in PBS/0 .1% BSA/0.02 % NaN3 were
kept for 15 min on ice, and washed. For two-color fluorescence, the cells were reacted with
unconjugated mAb to the first marker as above, followed by sequential 15-min exposures
to RaMIg-biotin (in the presence of 10% normal rat serum to block anti-rat Ig crossreac-
tivity), avidin-phycoerythrin plus 10 wg/ml normal mouse Ig, and FITC-labeled mAb to the
second marker. 2 x 104 cells per sample were analyzed in a FACScan flow cytometer (Becton
Dickinson). Light scatter gates were set to exclude dead cells and erythrocytes. Instrument
settings were identical for all experiments shown. Results are displayed as histograms or con-
tour plots generated with the FACScan and Consort 30 software (Becton Dickinson), respec-
tively.
Radioirnmunoprecipitation.
￿
Nylon wool-purified lymph node cells were surface labeled with
"I (Amersham Buchler GmbH, Braunschweig, FRG) by the lactoperoxidase method as pre-
viously described (14). Cells were lysed in lysis buffer (either PBS containing 1% NP-40 and
i mM PMSF or TRIS-buífered saline, pl4 7.5, containing 1 thM EDTA, 0.0236 NaN3, 1
mM PMSF, and 1% digitonin [Sigma Chemical Co.]). After centrifugation, the lysate was
preabsorbed with normal mouse IgG (Sigma Chemical Co.), coupled to cyanbromide-activated
sepharose beads (Pharmacia Fine Chemicals). The lysate was then incubated with the respec-
tive mAbs coupled to protein A-sepharose for 2 h at 4°C. The beads were washed four times
in lysis buffer containing 0.5 M KCl (NP40 lysates only) and two times with lysis buffer,
boiled for 5 min in nonreducing or reducing Laemmli sample buffer, respectively (16), and
the precipitated immune complexes were analyzed on SDS polyacrylamide gels.
Cell Culture.
￿
For T cell stimulation assays, 105 responder cells (unfractionated spleen cells
or purified T cells) were cultured in 0.1-ml microcultures for 3 d in RPMI 1640 with 5%
FCS in the presence or absence of various dilutions of R73 culture supernatants. In some
' Abbreviation used in this paper: RaMIg, rabbit anti-mouse Ig.groups, the microwell plates (Costar, Cambridge, MA) were precoated overnight with RaMIg
([Dakopatts GmbH]; 40 ug/ml in carbonate buffer, pH 9.5), while others received 10'
x-irradiated (1,200 rad) spleen cells as accessory cells. Where indicated, 50 U/ml human rIL-2
(Hoechst AG, Frankfurt, FRG) was added. 1 gCi['H]thymidine (Amersham, Braunschweig,
FRG; 5 Ci/mM sp act) was present in each well for the last 16 h ofculture before determining
the incorporated radioactivity by standard procedures.
For phenotypic analysis of R73-activated T cells, 5 x 105 purified T cells were cultured
in 2 ml RPMI 1640 and 5% FCS in tissue culture wells (Cluster 12; Costar) that had first
been coated with RaMIg as described above, followed by a 1-h incubation with a 1 :200 dilu-
tion of R73 or L180/1 ascitic fluid in medium, and three washes.
Results
Isolation of mAb R73.
￿
Spleen cells from a BALB/c mouse immunized with rat
T cell blasts and rat erythrocytes (see Materials and Methods) were fused with a
nonproducer myeloma cell line according to standard procedures. Culture superna-
tants were first screened for binding to rat leukocytes by indirect immunofluores-
cence, and positive cultures were tested for the induction of DNA synthesis in un-
fractionated rat spleen cells. One hybridoma, termed R73, scored positive and a
subclone yielding a high-titered tissue culture supernatant was isolated.
Tissue Distribution of the R73 Antigen.
￿
The tissue distribution of the R73 antigen
was investigated by immunofluorescence and flow cytometry and by immune histology.
Fig. 1 shows that in young adult animals, the antigen is expressed on -46% of spleno-
cytes, -63% of lymph node cells, and N3ojo of bone marrow cells. Thymocytes dis-
played a triphasic distribution of R73 staining. 13 % stained with the same intensity
as the positive cells found in spleen and lymph nodes, while the majority ofthymo-
cytes (68%) formed a distinct subpopulation with lower but clearly measurable an-
tigen expression, and a third population (19%) was R73 - .
Immune histology of splenic (Fig. 2 A) and lymph node (Fig. 2 B) sections re-
vealed that splenic R73 + cells reside in the T cell areas of the white pulp and
paracortex, respectively. This pattern was indistinguishable from that obtained in
serial sections for the pan T cell marker OX-52 (not shown). In the thymus (Fig.
2 C), almost all medullary cells reacted with R73, whereas the cortex contained only
scattered R73+ cells, many of which stained less intensely than medullary
thymocytes.
log green fluorescence
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FIGURE 1.
￿
Reactivity of mAb R73 with cell
suspensions prepared from spleen, lymph
nodes, bone marrow, and thymus of young
adult rats. Cells were stained with FITC-
conjugated mAbR73, andwith L180/1-FITC
as an isotype-matched negative control.76
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The above results
suggested that R73 detects apanTcell antigen. It was therefore attempted todefine
the exact subset(s) of peripheral lymphoid cells reactive with R73 using two-color
immunofluorescence and flow cytometry. In the experiment shown in Fig. 3, lymph
node lymphocytes were analyzed for coexpression of the R73 antigen with OX-52
(pan T cell), and the CD4 and CD8 markers found on MHC class II and class I
restricted peripheral T cells, respectively. Fig. 3 A indicates that all but a very small
subpopulation (2-3%) ofunseparated OX-52+ lymph node cells reacted with R73,
and that all R73+ cells also expressed OX-52, indicating that R73 detects a T
cell-specific antigen. Accordingly, purified lymph node T cells were analyzed for
coexpression ofR73 with CD4 and CD8 (Fig. 3, B-D). Virtually all (99.5%)lymph
node T cells expressing CD4 (Fig. 3 C) and -9517c ofCD8+ cells (Fig. 3 B) reacted
with R73. Simultaneous staining with both anti-CD4 and anti-CD8 in one fluores-
cence channel vs. R73 in the other revealed that R73 expression is restricted tolym-
phocytes expressing CD4 or CD8 (Fig. 3 D). It is of interest in this context that
rat NK cells are CD8+ (17), raising the possibility that R73 detects an antigen on
all helper and cytotoxic T cells, but not on NK cells.
Very similar results were obtained with rat splenocytes, except that an additional
population oflarger cells was found that expressed CD4 but was R73- (not shown).
These cells were negative for the pan T cell marker OX-52 and expressed CD4 at
a level below that characteristic ofperipheral T cells. Since rat splenic macrophages
have previously been shown to express the CD4 antigen (9), we conclude that these
were macrophages and that, like in lymph nodes, R73 expression in the spleen is
restricted to T lymphocytes.
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FIGURE 3.
￿
Expression of the
R73 determinant on subsetsof
lymphnode cells. Unseparated
(A)lymphnode cells or purified
Tcells (B-D)were stained with
thereagents as indicated in the
figure. Fordetails seeMaterials
and Methods. Lowest level
shown in contour plots is five
cells, graduation is 30 cells/line.
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Biochemical Characterization of the R73 Antigen .
￿
Lymph node cells were enriched
forT cells by nylon wool filtration, were surface iodinated, and were lysed with the
nonionic detergent NP-40 . Radioimmunoprecipitates obtained with R73 and, as
a control, normal mouse IgG were analyzed by SDS-PAGE in the absence or pres-
ence ofa reducing agent (Fig . 4 A) . R73 precipates a broad band characteristic of
glycoproteins with a molecular mass of 87 kD without reduction, and two bands
of 40 and 46 kD molecular mass upon reduction. Minor bands were also observed
that are presently unexplained . This result was consistent with the hypothesis that
mAb R73 is specific for the rat TCR-a/p . If so, immunoprecipitation from a lysate
prepared with a milder detergent such as digitonin, known to preserve TCR/CD3
complexes in other species, should yield one or several bands of smaller molecular
mass derived from theinvariantCD3 chains noncovalently associated with theTCR.
Fig . 4Bshows that under these conditions, an additional band of 26 kD was indeed
observed . It is likely that this band represents theCD3 S and/or s chains that comi-
grate as the major detectable CD3 components upon precipitation of the mouse
TCR/CD3 complex with an anticlonotypic antibody (8) .
RequirementsforT Cell Activation by mAbR73 .
￿
TheT cell specificity ofmAb R73
suggested that its stimulatory effect on rat splenocytes was directed at T cells . Ac-
cordingly, we compared the induction ofDNA synthesisby R73 in unseparated spleen
cells and in purified T lymphocytes (Fig. 5) . Titration of R73 culture supernatant
stimulated a dose-dependent response in unfractionated spleen cells (Fig. 5 A) . In
the experiment shown in Fig . 5 B, 105 nylon wool-purifiedlymph nodeT cells (98%
OX-52 + , 95% R73+ ) were cultured in the presence of serial dilutions of the same
R73 culturesupernatant . As judged by cell surface staining, themAb in this super-
FIGURE 4 .
￿
Radioimmunopre-
cipitation of the R73 antigen
analyzed by SDS-PAGE. (A)
mAb R73 (lanes 2 and 3), or
normal mouseIgG (lane 1)were
used for precipitation from an
NP-40 lysate of surface-
iodinated lymph node T cells .
(Lanes 1 and 2) Reduced,
12 .517o acrylamide ; (lane 3) non-
reduced, 10% acrylamide. (B)
mAb R73 (lanes 2 and 4) or
isotype-matched control mAb
L180/1 (lanes 1 and 3) were used
for precipitation from a digi-
tonin (lanes 1 and 2) or NP40
(lanes 3 and 4) lysate. 15%
acrylamide, reduced .a-
0 -t-
0
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FIGURE 5.
￿
T cell activation by mAb R73. Spleen cells (A), or purified lymph node T cells (B
andC) were incubatedfor3 dwith theadditionsindicated. FordetailsseeMaterialsandMethods.
Crossl., wellswere coated with RaMIgto crosslinkmAbR73. Sol., without crosslinking antibodies.
natant was able to saturate the R73 binding sites available on these T cells with a
titerof 1:500 (not shown). Without further additions, no proliferation was observed.
Even in thepresence of rIL-2, the lowlevel of DNA synthesis induced by IL-2 alone
was only slightly enhanced by soluble R73. If, however, the culture wells had been
precoated with RaMIg antibodies to crosslink the mAb, a clear-cut response above
background was observed that was enhanced by >10-fold by the addition of rIL-2.
Under theseexperimental conditions, amaximumresponse wasobserved at a 1,000-
fold dilution of theR73 culture supernatant, indicating that soluble, noncrosslinked
antibody interfered with T cell activation by antibody bound to the solid phase.
It is shownin Fig. 5 Cthat T cells from the same preparation did respond to soluble
R73 in thepresence ofirradiated spleen cellsas asource of accessorycells. Although
exogenous IL-2 was also able to enhance the proliferative response supported by
splenic accessory cells, the difference observed in cultures with and without rIL-2
was not as pronounced as in cultures stimulated by antibody crosslinked at the plastic
surface (Fig. 5 B).
Induction ofIL-2-R Expression andModulation of the R73 Antigen.
￿
Fig. 6 shows that
purified T cells cultured overnight in thepresence ofcrosslinked mAb R73 responded
at a high frequency (>807o) with an increase in cell size (A) and the expression of
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FIGURE 6.
￿
Phenotypic changes in T
cells after overnight incubation with
crosslinked mAb R73. Purified lymph
node T cells were cultured for 16 h in
the presence ofcrosslinked mAb R73
(dotted line) or isotype-matched mAb
L180/1 as a control (solid line). (A) for-
ward light scatter (linear); (B-D) im-
munofluorescence (log scale). (B) OX-
39-FITC (anti-IL-2-R); (C) R73 plus
RaMIg-biotin plus avidin-PE; (D)OX-
52-FITC . Negative staining controls
(not shown) were within the first log
decade.
OX 52
IL-2-Rs (B). Conversely, expression of the R73 antigen (C), but not ofthe OX-52
antigen (D) was 3-5-fold reduced on these cells as compared with control cells cul-
tured in the presence of a crosslinked isotype-matched antibody that does not react
with rat cells. Crosslinking ofthe rat CD2 antigendid not affect R73 antigen expres-
sion (not shown) .
Expression ofthe R73 Determinant on Subpopulations of Thymocytes.
￿
The availability
of an mAb that is likely to detect all TCRa/ß has prompted us to investigate the
expression ofthe R73 antigen on subpopulations of rat thymocytes. In particular,
we were interested to investigate a possible correlation between the triphasicprofile
noted before with regard to R73 staining intensity (Fig. 1) and subpopulations of
rat thymocytes previously defined by the markers CD4, CD8, and OX-44. In the
thymus, the latter antigen is exclusively expressed on functionally mature CD4 or
CD8 single-positive and on CD4-8- double-negative cells, while the major
CD4+8+ double-positive and the small CD4-CD8+ population from which these
double-positive cells mature are OX-44- (13).
The two parameter flow cytograms displayed in Fig. 7 make several interesting
points with regard to R73 expression on thymocyte subpopulations. Fig. 7 A, relating
cell sizeto R73 staining, defines at least three major subpopulations ofadult thymo-
cytes: large cells, most of which are R73- ; intermediate (lymphocyte)-sized cells
that express ahigh level ofthe antigen; and a large population the size ofsmall cor-
tical thymocytes that contains some negative, but mostly R73I°`" cells. Fig. 7, B and
C demonstrate the existence of a CD4- and ofa CD8- thymocyte subpopulation
that expresses R73 at alevel characteristic ofperipheral Tcells. It will become clear
from the following experiments that these are the two functionally mature thymo-
cyte subsets.
Next, thymocyte subsets were prepared by the panning technique and compared
with unfractionated thymocytes with regard to R73 staining (Fig. 8). Note that the
differences in background staining of the thymocyte subpopulations thus isolated
is due to the differences in cell size. Positively selected OX-44+ cells, shown in Fig.
8 B, contain the CM-8- cells, and in addition, the two functionally mature T cell
subpopulations (13). Staining with R73 revealed anegative subpopulation(ti30%),ö
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FIGURE 7.
￿
Expression ofthe R73 determinant on subpopulations detected in unseparated thymo-
cytes. Cells were stained and analyzed as given in Materials and Methods. Lowest level in con-
tour plots shown is five cells, graduation is 40 cells/line.
while -6717o of OX-44+ thymocytes expressed the antigen at the same level as pe-
ripheral T cells. As shown in Fig. 8 C, the R73- subpopulation could be attrib-
uted to the CD4- 8- cells contained in this preparation. Thus, the vast majority
(93.5%) of purified CD4-8- thymocytes were found to be negative for the putative
TCRa/ß. In contrast to the majority of R73-CD4-8- cells, which were all large
blasts, the small subpopulation of CD4-8- cells that expressed R73 (6.5%) con-
sisted mostly of lymphocyte-sized cells (not shown). OX-44- thymocytes (Fig. 8 D),
consisting of N90% CD4+8+ double-positive cells (13, and data not shown), were
mostly R731°", but also contained 25% R73- cells as well as a small subpopulation
(5 .1%) whose antigen density approached that of mature T cells.
Finally, the CD4- 8+ OX-44- thymic blast cells, which are the direct progenitors
of double-positive thymocytes, were isolated (18). These cells expressed from unde-
tectable to very lowbut significant amounts ofthe putative TCR-a/ß (Fig. 8 E). This
log green fluorescence
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FIGURE 8.
￿
Expression ofthe R73 determinant on isolated thymocyte subsets. Thymocytes were
separated by the panning technique into subsets as indicated and stained with FITC-R73 (solid
line) or FITC-L180/1 (negative control, dotted line).
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low but significant level of R73 staining was observed in all of five independent ex-
periments using various staining protocols.
Discussion
The conclusion that mAb R73 detects a constant determinant on the rat TCR-
a/p, although awaiting definite prooffrom transfection experiments or protein se-
quence analysis, is based on several independent observations that were compared
with the results previously reported for mouse and human TCRs (1). Thus, R73
detects a T cell-specific heterodimeric (40- and 46413) cell surface protein that is
expressed on the vast majority of (97-98%), but not on all, peripheral rat T cells.
This is analogous to the distribution ofTi-a/p vs. -y/8 expressing T cellsin humans
(2, 19). The expression of the R73 determinant on all CD4+ but only -90-95%
of CD8+ rat T cells is also in agreement with the reported CD8* phenotype of rat
(17) (and, in part, human, reference 20) NK cells, which are highly enriched in
CD8+R73- spleen cells (A. Lawetzky and T. Hünig, manuscript in preparation).
In addition, athymic rats, which have a higher ratio of NK to "classical" T cells,
contain up to 75% of R73- lymphocytes among their CD8+ spleen cells (A.
Lawetzky and T. Hünig, manuscript in preparation). It remains to be determined,
however, what fraction of CD8+ R73" cells are NK cells and/or express Ti-y/8
receptors as was reported for some human NK cell clones (21).
The T cell specificity of R73 staining observed with isolated leukocytes was in
full agreementwith its reactivity in thin sections oflymphoid organs (Fig. 2). These
experiments also provided the important information that in the thymus, strongly
R73+ cells reside almost exclusively in the medulla. This again correlated well with
the CD4 or CD8 single-positive, OX-44' phenotype of thymocytes expressing R73
at the level of peripheral T cells (Figs. 7 and 8). Finally, the requirements for T
cell activation with mAbR73 fully matched those reported formAbs to components
of the mouse (22) and human (23) Ti/CD3 complex in that antibody crosslinking
on an artificial surfaceor by Fc receptors on accessorycells was required forstimula-
tion. Thus, purified rat T cells responded to crosslinked R73 mAb at a high fre-
quency with blastoid transformation and IL-2-R expression (Fig. 6), but required
exogenous IL-2 forproliferation (Fig. 5 B). It may be added that using crosslinked
R73, Tcell clones canbe grownfrom small numbersofTcells ofunknown specificity,
an approach that will be helpful for the establishment ofclones from scarce sources
such as the cerebrospinal fluid or the synovial fluid, where specificity analysis of
T cells active in experimental autoimmune disease is amenable only after clonal
expansion.
Recent experiments on thymocytematuration and repertoire selection have raised
a number of challenging questions, some of which can now be addressed with the
help of the presentlydescribed mAb to aconstant determinant of the rat TCRa/p.
The results presented here show that the vast majority of the CD4-8- cells known
from other systems to contain the most immature thymocytes (24-26) are R73- .
Only 6% of R73+ cells were detected in this subpopulation, and they expressed the
putative TCRa/p at alevel characteristic of peripheral T cells. Moreover, two thirds
of this minor subpopulation was of lymphocyte, and not of blast size, leaving only
2% CD4-8- thymic blasts that express the R73 determinant. The TCR-a/0 has
been identified with the Vß8-specific mAb F23.1 on a considerably higher propor-HÜNIG ET AL.
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tion (up to 27%, reference 27) of adult mouse CD4-8- thymocytes (27-29). A lin-
eage assignment of these cells in thymic differentiation schemes is not possible yet,
but they are certainly distinct from the intrathymic stem cell population as judged
by their late appearance in ontogeny (29) and their inability to repopulate thymus
organ cultures (28).
The rat represents a particularly useful model for the in vitro study of thymocyte
differentiation due to the availability ofacell surface marker combination that allows
the isolation by negative selection of the immature CD8 single-positive blast cells
that have been shown to precede CD4'8+ double-positive cells in ontogeny (30-32)
and were recently identified as their direct precursors (18). Thus, thymocytes with
the phenotype CD4-8+ OX-44- acquire the double-positive phenotype upon over-
night incubation in suspension culturewithout overt stimulation (18), afindingthat
was recently confirmed in the mouse system (33). It is shown here (Fig. 8) that the
cells within this committed population of immature rat CD8 single-positivethymo-
cytes display a continuum of R73 antigen density from negative to weakly positive.
This is in agreement with the CD3d"ll phenotypeofCD8 immature mouse thymo-
cytes recently reported by Bluestone et al. (34) but disagrees with the CD3- status
ofthese cellsdescribed by MacDonaldet al. (33). Experimentsin progress (T Hiinig,
manuscript in preparation) indicate that upon in vitro cultivation for 1-2 d, most
rat CD8+ immature thymocytes acquire not only CD4, but also Ti levels charac-
teristic of double-positive thymocytes, i.e., higher than on their precursor cells but
distinctly lower than on mature T cells. We therefore speculatethat immature CD8
single-positive thymocytes havejust successfully rearranged their TCR a and ß loci
and are now committed to a pathway where coexpression of CD4, CD8, and inter-
mediate amounts of the TCR makes them available for repertoire selection. This
notion is in agreement with several reeent reports pointing to the expression of a
yet unselected repertoire on CD4+8+ thymocytes (7, 35, 36).
It is hopedthat the reagent described in the present communicationwill be useful
formonitoring andmanipulation ofTcell maturation andactivation in the rat system
in which the analysis oflymphoid subpopulations is greatly facilitated by theexten-
sive selection of mAbs to cell surface molecules that have been produced by other
laboratories .
Summary
mAb R73 detects a T cell-specific surface molecule consisting of two disulfide-
linked subunits of 40 and 46 kD, respectively, on 97% of peripheral rat T cells, as
defined by the OX-52 marker. Of the few OX-52+ R73- cells, none are CD4' but
many express the CD8 antigen known to be present on rat NK cells. mAb R73 is
mitogenic for unseparated spleen cells and for purified T cells. In the absence of
non-T "accessory cells", stimulation by R73 requires artificial erosslinking ofthemAb
and is largely dependent on exogenous IL-2. Overnight incubation of purified T
cells with crosslinked R73 mAb induces blastoid transformation, IL-2-R expression,
and modulation of the R73 antigen. In the rat thymus, mature medullary cellsex-
press the R73 determinant at the same level as peripheral T cells, whereas 94% of
CD4-CD8- thymocytes are R73- . The major CD4+8+ thymocyte population con-
tains 25% R73- and 70% R73' cells. Thymocytes ofthe CD4-CD8+OX44- sub-
population that are the direct precursors of CD4+CD8+ cells display a continuum84
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of R73 antigen density from undetectable to very low levels. We conclude that R73
is most likely directed at a constant determinant of the rat a/ß heterodimeric TCR
and suggest that CD8+ immature thymocytes are the first cells in the T cell differen-
tiation pathway to express this molecule at their surface.
We are greatly indebted to A. F. Williams, MRC Cellular Immunology Unit, Oxford, En-
gland, for helpful discussions and essential reagents; to Dr. Louise Beyers from the same
laboratory for histological staining; and to Dr. E .-L. Winnacker at the Genzentrum for his
continued support.
Receivedfor publication 23 May 1988 and in revisedform 27 September 1988.
References
1 . Marrack, P., and J. Kappler. 1987. The Tcell receptor. Science (Wash. DC). 238:1073.
2. Brenner, M. B., J. McLean, D. P Dialynas, J. L. Strominger, J. A. Smith, F. L. Owen,
J. G. Seidman, S. Ip, F. Rosen, and M. S. Krangel. 1986. Identification of a putative
second Tcell receptor. Nature (Lond). 322:145.
3. Maeda, L., N. Nakanishi, B. L. Rogers, W G. Haser, K. Shitara, H. Yoshida, Y. Tagagaki,
A. A. Augustin, and S. Tonegawa. 1987. Expression o£ the Tcell receptor y chain gene
products on the surface of peripheral Tcells and Tcell blasts generated by allogeneic
mixed lymphocyte reaction. Proc. Nadl. Acad. Sci. USA. 84:6536.
4. Haskins, K., C . Hannum, J . White, N . Roehm, R. Kubo, J. Kappler, and P Marrack.
1984. The antigen-specific, major histocompatibility complex-restricted receptor on T
cells. VI. An antibody to a receptor allotype. J Exp. Med. 160:452.
5 . Staerz, U. D., H.-G. Rammensee, J. D. Benedetto, and M. J. Bevan. 1985. Character-
ization of a murine monoclonal antibody specific for an allotypic determinant on Tcell
antigen receptor. J Immunol. 134 :3994.
6. Kappler, J. W., T. Wade, J. White, E. Kushnir, M. Blackman, J . Bill, N. Roehm, and
P Marrack. 1987. The Tcell receptor Vß segment that imparts reactivity to a class 11
major histocompatibility complex product. Cell. 49 :263.
7 . MacDonald, H. R., R. Schneider, R. K. Lees, R. C. Howe, H . Acha-Orbea, H . Festen-
stein, R. M. Zinkernagel, and H. Hengartner. 1988. Tcell Vß use predicts reactivity
and tolerance to MIsa-encoded antigens. Nature (Lond ). 332:40.
8. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987 . Identification
of an monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci.
USA. 84:1374.
9. Jefferies, W. A., J. R. Green, and A. R Williams. 1985. Authentic T helper CD4 (W3/25)
antigen on rat peritoneal macrophages. J Exp. Med. 162 :117 .
10. Brideau, R. J., P B. Carter, W. R. McMaster, D. W. Mason, and A. F. Williams. 1980.
Two subsets ofT lymphocytes defined with monoclonal antibodies. Eur.J Immunol. 10:609.
11 . Robinson, A. P, M. Puklavec, and D. W. Mason. 1986. MRC OX-52: a rat Tcell an-
tigen. Immunology. 57 :527.
12 . Paterson, D. J., W. A. Jefferies, J. R. Green, M. R. Brandon, P. Corthesy, M. Puklavec,
and A. F. Williams. 1987 . Antigens ofactivated rat T lymphocytes including a molecule
of 50000 M, detected only on CD4 positive T blasts. Mol. Immunol. 24:1281.
13 . Paterson, D. J ., J. R. Green, W. A. Jefferies, M. Puklavec, and A. F. Williams. 1987.
The MRC OX-44 antigen marks a functionally relevant subset among rat thymocytes.
J. Exp. Med. 165:1 .
14. Hilnig, T. 1985. The cell surface recognized by the erythrocyte receptor of T lympho-
cytes. Identification and partial characterization using a monoclonal antibody.,/. Exp.
Med. 162:890.HÜNIG ET AL.
￿
85
15. Wysocki, L. J., and V. L. Sato. 1978. "Panning" for lymphocytes: a method for cell selec-
tion. Proc. Nad. Acad. Sci. USA. 75:2884.
16. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head
of the bacteriophage T4 . Nature (Loud.). 227:680.
17 . Reynolds, C. W., S. O. Sharrow, J. R. Ortaldo, and R. B. Herbermann. 1981 . Natural
killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometryf
Immunol. 127 :2204.
18 . Paterson, D.J., and A. L. Williams. 1987. An intermediate cell in thymocyte differentia-
tion that expresses CD8 but not CD4 antigen. J. Exp. Med. 166:1603.
19 . Weiss, A., M. Newton, and D. Crommie. 1986. Expression of T3 in association with
a molecule distinct from the T-cell antigen receptor heterodimer. Proc. Nad. Acad. Sci.
USA. 83:6998.
20 . Faure, F., S. Jitsukawa, F Triebel, and T. Hercend. 1988. CD3/TiyA: a functional y-re-
ceptor complex expressed on human peripheral lymphocytes. f Immunol. 140:1372.
21 . Nowill, A., I? Moingeon, A. Ythier, M. Graziani, F. Faure, L. Delmon, M . Rainaut,
F. Forestier, C. Bohuon, and T. Hercend. 1986. Natural clones derived from fetal (25
wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody.j Exp.
Med. 163:1601.
22 . Crispe, I. N., M . J. Bevan, and U. D. Staerz. 1985. Selective activation of Lyt2'
precursor Tcells by ligation of the antigen receptor. Nature (Land.). 317:627 .
23 . Meuer, S. C ., J. C. Hodgdon, R. E. Hussey, J. P Protentis, S. F. Schlossman, and E. L.
Reinherz. 1983 . Antigen-like effects of monoclonal antibodies directed at receptors on
human T cell clones. J. Exp. Med. 158:989.
24. Scollay R., P. Bartlet, and K. Shortman. 1984. Tcell development in the adult murine
thymus: changes in the expression ofthe surface antigens Ly2, L3T4, and B2A2 during
development from early precursor cells to emigrants. Immunol. Rev. 89:79.
25 . Kisielow, P., W. Leiserson, and H. van Boehmer. 1984. Differentiation of thymocytes
in fetal organ culture: analysis of phenotypic changes accompanying the appearance of
cytolytic and interleukin 2-producing cells. J. Immunol. 133:1117.
26. Fowlkes, B. J ., L. Edison, B. J. Mathieson, and T M. Chused. 1985. Early T lympho-
cytes. Differentiation in vivo of adult intrathymic precursor cells. j Exp. Med. 162:802.
27 . Wilson, A., T Ewing, T Owens, R. Scollay and K. Shortman. 1988. Tcell antigen receptor
expression by subsets of Ly2 - L3T4- (CD8- CD4- ) thymocytes. f Immunol. 140:1470.
28 . Crispe, I. N., M. W. Moore, L. A. Husmann, L. Smith, M. J. Bevan, and R. P.
Shimonkevitz. 1987 . Differentiation potential of subsets of CD4- 8- thymocytes. Nature
(Land.). 329:336.
29 . Fowlkes, B. J., A. M. Kruisbeek, H. TonThat, M. A. Weston, J. E . Coligan, R. H.
Schwartz, and D. M. Pardoll. 1987. A novel population of T-cell receptor a/ß bearing
thymocytes which predominantly expresses a single Vß gene family. Nature (Land.).
329:251.
30 . Ceredig, R., D. P Dialynas, F. W. Fitch, and H. R. MacDonald. 1983. Precursors of
T cell growth factor producing cells in the thymus. Ontogeny, frequency, and quantita-
tive recovery in a subpopulation of phenotypically mature thymocytes defined by mono-
clonal antibody GK-1.5. J. Exp. Med. 158:1654.
31 . Mackay, C. R., J . F. Maddox, and M. R. Brandon. 1986. Thymocyte subpopulations
during early fetal development in sheep. f. Immunol. 136:1592.
32 . Von Boehmer, H. 1986. Thymus development. Curr. Top. Microbial. Immunol. 126:19.
33 . MacDonald, H . R., R. C. Budd, and R. C. Howe. 1988. A CD3- subset of CD4- 8'
thymocytes: a rapidly cycling intermediate in the generation of CD4' 8' cells. Eur. f.
Immunol. 18:519.
34 . Bluestone, J. A., D. Pardoll, S. O. Sharrow, and B. J. Fowlkes. 1987 . Characterization86
￿
IDENTIFICATION OF THE RAT T CELL RECEPTOR
of murine thymocytes with CD3-associated Tcell receptor structures. Nature (Lond).
326:82.
35. Kappler, J. W., N. Roehm, and P. Marrack. 1987. Tcell tolerance by clonal elimination
in the thymus. Cell. 49:273.
36. Kappler, J . W., U. Staerz, J . White, and P C . Marrack. 1988. Self-tolerance eliminates
Tcells specific for Mls-modified products of the major histocompatibility complex. Na-
ture (Lond). 332:35.